News & Publications

News & insights

Penningtons Manches Cooper advises electrospinning medtech company on Series A funding
Posted: 12/08/2019
Penningtons Manches Cooper has acted for the Electrospinning Company on its £1.5 million Series A fund raising led by London-based venture capital firm Downing Ventures, alongside VC firm MidVen, Newable Private Investing and the UK Science and Technology Facilities Council (STFC)......>>
Penningtons Manches Cooper advises Oxford Drug Design on equity funding round led by o2h Ventures
Posted: 03/07/2019
Penningtons Manches Cooper has acted for Oxford Drug Design on an equity investment led by o2h Ventures......>>
Penningtons Manches advises on sale of Chemtest Group
Posted: 17/04/2019
Penningtons Manches' corporate team has advised the shareholders of Newmarket-based Chemtest on its acquisition by Eurofins Scientific, the world’s largest group of laboratories. Cambridge corporate partner Helen Drayton led the Penningtons Manches team, supported by associate Katharine Robinson......>>
Contingency legislation covering regulation of medicines, medical devices and clinical trials in a no deal scenario
Posted: 11/03/2019
The draft Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019 (draft 2019 Clinical Trials Regulations) will come into place if the UK exits the EU without a deal. The UK is currently scheduled to leave the EU on 29 March 2019 (exit day)......>>
Implementation is key to transforming the Arc
Posted: 02/11/2018
The Arc is essential to the future prosperity of the UK. The stretch of the country between Cambridge, Milton Keynes and Oxford offers huge potential to build the infrastructure that will cement the UK’s position as a world leader in science, technology and related fields......>>

Read all life sciences news & insights

Publications

E-Bulletins

Life sciences update - Summer 2019
In this issue: It’s a busy time of year in the life sciences event calendar, including the recent OBN ‘BioTrinity’ conference in London, and forthcoming One Nucleus ‘ON Helix’ conference.

Life sciences update - Winter 2019
In this issue: Since the MPs’ vote on the Brexit deal on 15 January 2019, the UK continues to face a high level of uncertainty in the coming months and years, with the exit date of 29 March drawing closer, and a ‘no deal’ Brexit looking more and more likely. The life sciences sector, heavily governed by EU Regulations, is likely to be affected.

Life sciences update - Spring 2018
In this issue: Welcome to the spring edition of Bio Brief. To celebrate spring (despite the somewhat unseasonal and changeable weather), we have made some changes to the layout which we hope will reflect the new growth in the life sciences sector.

Life sciences update - Winter 2018
In this issue: Welcome to the first edition of Bio Brief for 2018. As usual across the life sciences sector there is a lot of activity reflecting the breadth and dynamism of the sector. We aim to support your business by providing you with a variety of articles reflecting both recent case law and major legal changes on the horizon.

Life sciences update - May 2017
In this issue: The formal process for the UK’s departure from the EU began on 29 March 2017 when the UK Government notified the European Council under Article 50 of the Lisbon Treaty of its intention to leave the EU. In this article, we review the impact of Brexit on different categories of IP rights.

View all life sciences e-bulletins

Brochures & factsheets

Life sciences fact sheet
In the fast-moving and competitive field of life sciences, effective legal support is essential. Our award-winning life sciences practice provides comprehensive, business-oriented advice to biotech, pharmaceutical and medical device clients.

Return to Life sciences

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3010
+44 (0)7833 793595 (out of hours)

Useful links

Contact an office

London (Head office)
+44 (0)20 7457 3000
London (Minories)
+44 (0)20 7481 8851
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
San Francisco
+1 415 712 2869
São Paulo
+55 11 3938.1900
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2019 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority.